Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Martin Hauer‐Jensen

High Impact

Retired

Also affiliated: Tokyo Institute of Technology (2000); University of Iowa (1986–1990); Oslo University Hospital (1986–1994); American Heart Association (2006); Boston Medical Center (2010); National Institutes of Health (2001–2010); Memorial Sloan Kettering Cancer Center (2010); New York Blood Center (2001); Thomas Jefferson University (2010); University of Oslo (1986–1990); Medical College of Wisconsin (2010); University of Arkansas Medical Center (1997–2025); Maastricht University Medical Centre (2010); Henry Ford Hospital (2010); Moffitt Cancer Center (2012); Maastricht University (2010); Central Arkansas Veterans Healthcare System (1999–2018); Diakonhjemmet Hospital (1980–1986); Iowa City VA Medical Center (1987); National Cancer Institute (2010); Lovisenberg Diakonale Sykehus (1986); Arkansas Biosciences Institute (2006); John L. McClellan Memorial Veterans Hospital (1993–2009); Maastro Clinic (2010); University of Florida Cancer Hospital (2010); UF Health Cancer Center (2010); University of Bergen (2000); Charité - Universitätsmedizin Berlin (2012)

66 h-index 330 pubs 18,244 cited

  • Animals
  • Male
  • Humans
  • Mice
  • Rats
  • Radiation Injuries, Experimental
  • Radiation-Protective Agents
  • Radiation Injuries
  • Rats, Sprague-Dawley
  • Female
  • Intestinal Mucosa
  • Whole-Body Irradiation
  • Dose-Response Relationship, Radiation
  • Mice, Inbred C57BL
  • Time Factors

Biography and Research Information

OverviewAI-generated summary

Martin Hauer‐Jensen, a retired researcher from the University of Arkansas for Medical Sciences, has a scholarly career marked by extensive work in radiation biology and its associated medical countermeasures. His research has focused on understanding the mechanisms of radiation injury, particularly its early and late effects on normal tissues and organs. This work has informed radiation protection contexts by defining threshold doses for tissue reactions.

Hauer‐Jensen has investigated animal models for evaluating agents intended for the prophylaxis, mitigation, and treatment of radiation injuries. His publications also touch upon the broader implications of radiation therapy, including its impact on mucosal injury and the development of conditions like radiation enteropathy. His research network includes collaborators such as Vijayalakshmi Sridharan, Benjamin J. Lieblong, Isabelle R. Miousse, and Rupak Pathak, with whom he has co-authored multiple publications.

With a significant body of work, Hauer‐Jensen has achieved a high-impact researcher designation, evidenced by an h-index of 65 and over 18,000 citations across more than 330 publications. His recent activity indicates continued engagement in the field, with a publication as recent as 2026.

Metrics

  • h-index: 66
  • Publications: 330
  • Citations: 18,244

Positions

  • Retired publications 1992–2026
    University of Arkansas for Medical Sciences Pharmaceutical Sciences ORCID

Selected Publications

  • Serum Proteomic Signatures in Nonhuman Primates after Treatment with a Radiation Countermeasure and Exposure to a Partial- or Total-body Supralethal Radiation Dose (2025)
  • Exposure to a Single Dose of Space-Relevant Proton Radiation Alters the Intestinal One-Carbon Metabolism Pathway and Microbiome in Mice (2025)
  • Serum Metabolomic Signatures in Nonhuman Primates Treated with a Countermeasure and Exposed to Partial- or Total-Body Radiation (2025)
  • Pathology of acute sub-lethal or near-lethal irradiation of nonhuman primates prophylaxed with the nutraceutical, gamma tocotrienol (2024)
    1 citation DOI OpenAlex
  • Don't CUT: Respecting the Potency of Radiation (2024)
    1 citation DOI OpenAlex
  • Histopathological studies of nonhuman primates exposed to supralethal doses of total- or partial-body radiation: influence of a medical countermeasure, gamma-tocotrienol (2024)
    4 citations DOI OpenAlex
  • Modulation of Hematopoietic Injury by a Promising Radioprotector, Gamma-Tocotrienol, in Rhesus Macaques Exposed to Partial-Body Radiation (2023)
    10 citations DOI OpenAlex
  • Gamma-Tocotrienol Modulates Total-Body Irradiation-Induced Hematopoietic Injury in a Nonhuman Primate Model (2022)
    International Journal of Molecular Sciences 21 citations DOI OpenAlex
  • Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model (2022)
    Antioxidants 20 citations DOI OpenAlex
  • Cytogenetic and epigenetic aberrations in peripheral lymphocytes of northwest Arkansas Marshallese (2022)
    9 citations DOI OpenAlex
  • Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate (2022)
    International Journal of Molecular Sciences 28 citations DOI OpenAlex
  • Randomised single centre double-blind placebo controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline in patients suffering long-term gastrointestinal adverse effects of radiotherapy for pelvic cancer: The PPALM study (2022)
    10 citations DOI OpenAlex
  • Methods for induction and assessment of intestinal permeability in rodent models of radiation injury (2022)
    3 citations DOI OpenAlex
  • Plasma Metabolomics in a Nonhuman Primate Model of Abdominal Radiation Exposure (2021)
    2 citations DOI OpenAlex
  • Dietary Methionine Deficiency Enhances Genetic Instability in Murine Immune Cells (2021)
    11 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

535 Collaborators 174 Institutions 19 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics